海南海药(000566)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

000566 海南海药

交易中 02-12 13:58:09

{"stockData":{"symbol":"000566","market":"SZ","secType":"STK","nameCN":"海南海药","latestPrice":6.23,"timestamp":1770875889000,"preClose":6.3,"halted":0,"volume":16941894,"delay":0,"changeRate":-0.0111,"floatShares":1297000000,"shares":1297000000,"eps":-1.1349,"marketStatus":"交易中","change":-0.07,"latestTime":"02-12 13:58:09","open":6.28,"high":6.32,"low":6.21,"amount":106000000,"amplitude":0.0175,"askPrice":6.24,"askSize":3149,"bidPrice":6.23,"bidSize":2215,"shortable":0,"etf":0,"ttmEps":-1.1349,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770879600000},"marketStatusCode":2,"adr":0,"adjPreClose":6.3,"symbolType":"stock","openAndCloseTimeList":[[1770859800000,1770867000000],[1770872400000,1770879600000]],"highLimit":6.93,"lowLimit":5.67,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1297365126,"isCdr":false,"pbRate":29.36,"roa":"--","roe":"--","epsLYR":-1.1756,"committee":0.388725,"marketValue":8083000000,"turnoverRate":0.0131,"status":1,"floatMarketCap":8079000000},"requestUrl":"/m/hq/s/000566","defaultTab":"news","newsList":[{"id":"2608633143","title":"2月4日海南海药发布公告，股东减持342.73万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608633143","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608633143?lang=zh_cn&edition=full","pubTime":"2026-02-04 19:16","pubTimestamp":1770203794,"startTime":"0","endTime":"0","summary":"证券之星消息，2月4日海南海药发布公告《海南海药:简式权益变动报告书(云南国际信托有限公司－聚利36号单一资金信托)》，其股东云南国际信托有限公司-聚利36号单一资金信托于2026年2月2日合计减持342.73万股，占公司目前总股本的0.2642%，变动期间该股股价下跌3.87%，截止2月2日收盘报6.21元。股东增减持详情见下表：    根据海南海药2025年三季报公布的十大股东详情如下：    为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202602/04/20260204931582.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202602/04/20260204931582.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260204/31998547.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","BK0070","BK0188","BK0060","BK0146","000566"],"gpt_icon":0},{"id":"2608132350","title":"海南海药最新公告：副总经理张晖因到龄退休辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2608132350","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608132350?lang=zh_cn&edition=full","pubTime":"2026-02-04 18:39","pubTimestamp":1770201577,"startTime":"0","endTime":"0","summary":"海南海药(000566.SZ)公告称，公司董事会近日收到副总经理张晖的辞职报告，其因到龄退休申请辞去公司副总经理职务。辞职后，张晖将不再担任海南海药任何职务。张晖现持有公司股份365,372股，辞职后其持有的公司股份将继续按照相关规定进行管理。海南海药及董事会对张晖在任职期间的贡献表示感谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400034330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0060","BK0239","000566","BK0146","BK0188"],"gpt_icon":0},{"id":"2608884857","title":"股市必读：海南海药（000566）预计2025年全年扣除后营业收入:78,000万元至88,000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608884857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608884857?lang=zh_cn&edition=full","pubTime":"2026-02-02 05:12","pubTimestamp":1769980335,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，海南海药报收于6.46元，上涨0.31%，换手率2.93%，成交量38.0万手，成交额2.47亿元。业绩披露要点业绩预告海南海药发布业绩预告，预计2025年全年扣非后净利润亏损3.8亿元至4.8亿元。预计2025年全年扣除后营业收入7.8亿元至8.8亿元。公司公告汇总2025年度业绩预告海南海药预计2025年度归属于上市公司股东的净利润亏损35,000万元至43,000万元，亏损额较上年同期下降。具体财务数据以2025年年度报告为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200002437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566"],"gpt_icon":0},{"id":"2607043081","title":"海南海药最新公告：预计2025年净亏损3.50亿元-4.30亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607043081","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607043081?lang=zh_cn&edition=full","pubTime":"2026-01-30 21:09","pubTimestamp":1769778562,"startTime":"0","endTime":"0","summary":"海南海药(000566.SZ)公告称，预计2025年归属于上市公司股东的净利润为亏损35,000万元至43,000万元。业绩变动主要原因系销售费用、信用减值损失、公允价值变动损失、资产减值损失同比减少，以及投资收益同比上升所致。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000044691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0060","BK0239","BK0188","000566","BK0146"],"gpt_icon":0},{"id":"2605496010","title":"海南海药：加快新产品上市与创新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2605496010","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605496010?lang=zh_cn&edition=full","pubTime":"2026-01-22 20:52","pubTimestamp":1769086376,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药01月22日在投资者关系平台上答复投资者关心的问题。公司正在努力提升经营业绩为股东创造价值，感谢您的理解和关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200038615.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK1161","159992","BK1574","BK0146","06978","BK0070","BK0188","000566","BK0239"],"gpt_icon":0},{"id":"2602754883","title":"海南海药最新公告：创新药派恩加滨片Ⅱa期临床试验研究结果发布","url":"https://stock-news.laohu8.com/highlight/detail?id=2602754883","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602754883?lang=zh_cn&edition=full","pubTime":"2026-01-09 20:50","pubTimestamp":1767963010,"startTime":"0","endTime":"0","summary":"海南海药(000566.SZ)公告称，公司全资子公司海口市制药厂有限公司与中国科学院上海药物研究所联合研究开发的创新药派恩加滨项目，于近日完成了Ⅱa期临床试验，初步研究结果显示达到主要及次要临床终点。派恩加滨属于化药1类，为新型抗癫痫药物，新一代KCNQ钾通道激动剂，目前全球尚无上市品种，本品可用于难治性癫痫的治疗。本次仅为派恩加滨完成中国Ⅱa期临床试验结果分析，后续尚需完成Ⅱb期及Ⅲ期临床试验，并经国家药监局批准后方可上市。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900038074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","06978","BK1574","BK0239","BK0146","000566","159992","BK0060","BK1161","BK0188"],"gpt_icon":0},{"id":"2602737293","title":"海南海药：股东云南国际信托拟减持不超过1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602737293","media":"新京报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602737293?lang=zh_cn&edition=full","pubTime":"2026-01-09 20:31","pubTimestamp":1767961860,"startTime":"0","endTime":"0","summary":"新京报贝壳财经讯 1月9日，海南海药公告，持股5%以上股东云南国际信托有限公司-聚利36号单一资金信托持有公司6829.55万股，占5.26%，因资金需求，拟于本公告披露之日起15个交易日后的连续90个自然日内，以集中竞价方式减持不超过1297.37万股，占1%；股份来源为要约收购所得，减持价格将按届时市场价确定。","market":"sh","thumbnail":"https://media.bjnews.com.cn/cover/2026/01/07/5673058989907193474.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2026/01/07/5673058989907193474.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1767961393129047.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1767961393129047.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["BK0146","000566","BK0060","BK0070","BK0239","BK0188"],"gpt_icon":0},{"id":"2601335586","title":"异动快报：海南海药（000566）1月8日9点37分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2601335586","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601335586?lang=zh_cn&edition=full","pubTime":"2026-01-08 09:41","pubTimestamp":1767836480,"startTime":"0","endTime":"0","summary":"证券之星1月8日盘中消息，9点37分海南海药触及涨停板。其所属行业化学制药目前上涨。领涨股为必贝特。该股为创新药，化学原料药，医药概念热股，当日创新药概念上涨1.02%，化学原料药概念上涨0.91%，医药概念上涨0.78%。1月7日的资金流向数据方面，主力资金净流出6692.61万元，占总成交额9.79%，游资资金净流出894.93万元，占总成交额1.31%，散户资金净流入7587.54万元，占总成交额11.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800008170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","000566","BK0146","BK0060","BK0070"],"gpt_icon":0},{"id":"2601209738","title":"海南海药：截至2025年12月31日股东户数为129,547","url":"https://stock-news.laohu8.com/highlight/detail?id=2601209738","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601209738?lang=zh_cn&edition=full","pubTime":"2026-01-07 15:51","pubTimestamp":1767772273,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药(000566)01月06日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘：请问截止到2025年12月31日，股东户数是多少？谢谢海南海药回复：您好，截至2025年12月31日公司股东户数为129,547。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700018589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0060","BK0146","BK0188","000566","BK0239"],"gpt_icon":0},{"id":"2594252848","title":"海南海药（000566）1.31亿股限售股将于12月26日解禁，占总股本10.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594252848","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594252848?lang=zh_cn&edition=full","pubTime":"2025-12-26 08:11","pubTimestamp":1766707876,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，海南海药于12月26日将有1.31亿股限售股份解禁，为公司定向增发机构配售股份，占公司总股本10.08%。本次解禁后，公司还有62.95万股限售股份，占总股本0.05%。海南海药主营业务：药品及医疗器械研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600003628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0060","BK0239","000566","BK0146","BK0188"],"gpt_icon":0},{"id":"2593447239","title":"海南海药：公司目前未触及退市风险警示规定情形","url":"https://stock-news.laohu8.com/highlight/detail?id=2593447239","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593447239?lang=zh_cn&edition=full","pubTime":"2025-12-24 20:52","pubTimestamp":1766580733,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药12月23日在投资者关系平台上答复投资者关心的问题。我们给一个答复海南海药回复：您好，根据《深圳证券交易所股票上市规则》第九章相关规定:\"上市公司最近一个会计年度经审计的利润总额、净利润、扣除非经常性损益后的净利润三者孰低为负值，且扣除后的营业收入低于3亿元。\"深交所对其股票交易实施退市风险警示。公司目前未触及上述规定情形。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400037452.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","000566","BK0146","BK0060","BK0070"],"gpt_icon":0},{"id":"2593114491","title":"3连板海南海药：1.31亿股将于12月26日解除限售","url":"https://stock-news.laohu8.com/highlight/detail?id=2593114491","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593114491?lang=zh_cn&edition=full","pubTime":"2025-12-23 18:50","pubTimestamp":1766487056,"startTime":"0","endTime":"0","summary":"海南海药(000566.SZ)公告称，公司2016年度非公开发行限售股份1.31亿股将于2025年12月26日上市流通，占公司总股本的10.08%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300031234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","000566","BK0060","BK0070","BK0239","BK0188"],"gpt_icon":0},{"id":"2593615177","title":"异动快报：海南海药（000566）12月22日10点11分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2593615177","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593615177?lang=zh_cn&edition=full","pubTime":"2025-12-22 10:15","pubTimestamp":1766369722,"startTime":"0","endTime":"0","summary":"证券之星12月22日盘中消息，10点11分海南海药触及涨停板。其所属行业化学制药目前上涨。领涨股为康芝药业。该股为海南概念，海南自由贸易港，自由贸易港概念热股，当日海南概念概念上涨8.83%，海南自由贸易港概念上涨8.33%，自由贸易港概念上涨3.91%。12月19日的资金流向数据方面，主力资金净流入1.57亿元，占总成交额17.13%，游资资金净流出5828.75万元，占总成交额6.38%，散户资金净流出9829.78万元，占总成交额10.75%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200004124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0188","BK0146","000566","BK0239","BK0060"],"gpt_icon":0},{"id":"2592687153","title":"异动快报：海南海药（000566）12月19日14点14分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2592687153","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592687153?lang=zh_cn&edition=full","pubTime":"2025-12-19 14:15","pubTimestamp":1766124927,"startTime":"0","endTime":"0","summary":"证券之星12月19日盘中消息，14点14分海南海药触及涨停板。其所属行业化学制药目前上涨。领涨股为新诺威。该股为海南自由贸易港，海南概念，自由贸易港概念热股，当日海南自由贸易港概念上涨4.71%，海南概念概念上涨4.42%，自由贸易港概念上涨2.84%。12月18日的资金流向数据方面，主力资金净流出4418.7万元，占总成交额7.98%，游资资金净流入326.33万元，占总成交额0.59%，散户资金净流入4092.37万元，占总成交额7.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121900017066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0060","BK0239","BK0188","000566","BK0146"],"gpt_icon":0},{"id":"2590669415","title":"海南海药修订董事会提名委员会议事规则，强化董事及高管选任程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2590669415","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590669415?lang=zh_cn&edition=full","pubTime":"2025-12-11 11:54","pubTimestamp":1765425249,"startTime":"0","endTime":"0","summary":"中访网数据 海南海药股份有限公司于近期修订了其董事会提名委员会议事规则。根据修订后的规则，提名委员会由三名以上董事组成，其中独立董事须占半数以上，委员会召集人由董事长担任。规则明确，若董事会未采纳委员会建议，需在决议中记载相关意见及未采纳理由并予以披露。委员与审议事项存在利害关系时应予回避。此次修订旨在进一步规范公司董事和高级管理人员的产生机制，完善公司治理结构。规则自董事会决议通过之日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251211/31858711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0070","BK0060","BK0239","000566","BK0188","BK0146"],"gpt_icon":0},{"id":"2590568101","title":"海南海药拟续聘中审众环为2025年度审计机构","url":"https://stock-news.laohu8.com/highlight/detail?id=2590568101","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590568101?lang=zh_cn&edition=full","pubTime":"2025-12-11 10:13","pubTimestamp":1765419221,"startTime":"0","endTime":"0","summary":"中访网数据 海南海药股份有限公司于2025年12月10日召开董事会会议，审议通过了关于续聘会计师事务所的议案。公司拟继续聘请中审众环会计师事务所担任2025年度财务报告及内部控制审计机构，聘期一年。　　公司董事会审计委员会已对中审众环的专业胜任能力、诚信状况及独立性等进行审查，认为其能够满足公司2025年度审计工作的要求，故同意续聘并提交董事会及股东大会审议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251211/31858490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0070","BK0060","BK0239","000566","BK0146","BK0188"],"gpt_icon":0},{"id":"2589893148","title":"海南海药（000566）披露关于股东表决权让渡终止暨权益变动的提示性公告，12月05日股价上涨0.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589893148","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589893148?lang=zh_cn&edition=full","pubTime":"2025-12-05 17:46","pubTimestamp":1764927987,"startTime":"0","endTime":"0","summary":"截至2025年12月5日收盘，海南海药报收于8.14元，较前一交易日上涨0.62%，最新总市值为105.61亿元。公司近日发布《关于股东表决权让渡终止暨权益变动的提示性公告》。公告显示，因合同纠纷执行案件，武汉中院通过司法拍卖、变卖南方同正所持海南海药部分股票，导致南方同正被动减持公司股份合计130,825,900股，占公司总股本的10.08%。本次权益变动后，华同实业拥有表决权股份由30.88%降至22.89%，南方同正及其一致行动人合计持有5.46%股份并恢复对应表决权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500027661.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0060","BK0146","000566","BK0070"],"gpt_icon":0},{"id":"2588305334","title":"海南海药：截至2025年11月30日股东户数为142,682","url":"https://stock-news.laohu8.com/highlight/detail?id=2588305334","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588305334?lang=zh_cn&edition=full","pubTime":"2025-12-02 20:52","pubTimestamp":1764679968,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药(000566)12月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘：请问截止到2025年11月30日，股东户数是多少？谢谢海南海药回复：您好，截至2025年11月30日，公司股东户数为142,682。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200036938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0146","BK0060","BK0070","000566","BK0188"],"gpt_icon":0},{"id":"2588305338","title":"海南海药：氟非尼酮III期临床已开始筹备","url":"https://stock-news.laohu8.com/highlight/detail?id=2588305338","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588305338?lang=zh_cn&edition=full","pubTime":"2025-12-02 20:52","pubTimestamp":1764679958,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药(000566)12月02日在投资者关系平台上答复投资者关心的问题。投资者提问：海南海药在创新药方向有什么成果？海南海药回复：您好，公司抗肝纤维化 1 类新药氟非尼酮胶囊完成Ⅱ期临床试验期中分析，目前氟非尼酮III期临床已开始筹备工作。抗癫痫1 类新药派恩加滨，正在开展Ⅱa 期临床研究，目前受试者已全部出组，正在开展相关数据分析。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200036931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0060","000566","BK0146","BK0070"],"gpt_icon":0},{"id":"2588053381","title":"海南海药：有盐酸金刚烷胺片用于防治甲流","url":"https://stock-news.laohu8.com/highlight/detail?id=2588053381","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588053381?lang=zh_cn&edition=full","pubTime":"2025-12-02 20:52","pubTimestamp":1764679957,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药(000566)12月02日在投资者关系平台上答复投资者关心的问题。投资者提问：海南海药有治疗流感相关药吗？对最近的流感有治疗效果吗？海南海药回复：您好，近期流感以甲流为主，目前公司针对甲流相关症状治疗药物有盐酸金刚烷胺片，用于帕金森病、帕金森综合征、药物诱发的锥体外系疾患，一氧化碳中毒后帕金森综合征及老年人合并有脑动脉硬化的帕金森综合征，也用于防治A型流感病毒所引起的呼吸道感染，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200036926.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","BK0146","000566","BK0188","BK0060"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770875892654,"stockEarnings":[{"period":"1week","weight":-0.0063},{"period":"1month","weight":-0.1566},{"period":"3month","weight":0.0244},{"period":"6month","weight":0},{"period":"1year","weight":0.2963},{"period":"ytd","weight":-0.1189}],"compareEarnings":[{"period":"1week","weight":0.0073},{"period":"1month","weight":-0.008},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1177},{"period":"1year","weight":0.2453},{"period":"ytd","weight":0.0411}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"海南海药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"128790人(较上一季度增加0.00%)","perCapita":"10068股","listingDate":"1994-05-25","address":"海南省海口市秀英区南海大道192号","registeredCapital":"129736万元","survey":"　　海南海药股份有限公司的主营业务是药品研发、生产和销售。公司的主要产品是注射用头孢西丁钠、注射用头孢唑肟钠、注射用美罗培南、注射用氨曲南、注射用头孢呋辛钠、注射用头孢曲松钠、头孢克洛颗粒、头孢克洛干混悬剂、注射用头孢美唑钠、枫蓼肠胃康口服液、枫蓼肠胃康分散片、聚乙二醇4000散、醋氨己酸锌胶囊、紫杉醇注射液、复方红豆杉胶囊、小柴胡颗粒。","listedPrice":5.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海南海药(000566)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海南海药(000566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海南海药,000566,海南海药股票,海南海药股票老虎,海南海药股票老虎国际,海南海药行情,海南海药股票行情,海南海药股价,海南海药股市,海南海药股票价格,海南海药股票交易,海南海药股票购买,海南海药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海南海药(000566)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海南海药(000566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}